4 ms·
COVAX had nothing to do with an "open source" model, it was about better distribution of the existing vaccine supplies. There were early concerns that IP right
by zozbot234 5y ago
COVAX had nothing to do with an "open source" model, it was about better distribution of the existing vaccine supplies. There were early concerns that IP rights enforcement might make it harder to develop and supply SARS-CoV2 vaccines, but a patent waiver was ultimately agreed upon. It made very little difference in the end because effective vaccines (such as those based on mRNA) are not like other drugs, and there are inherent constraints to expanding supply or making a "generic" version.
- goodpoint 5y agoThat is why I wrote "... or at least ...". The other proposal (whose name I don't remember) was to share the IP.